# NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS

> **NIH NIH N01** · ADVANCED BIOSCIENCE LABORATORIES, INC. · 2022 · $346,256

## Abstract

This contract will provide NIAID with a broad and flexible range of nontraditional, proactive and developmentally-oriented capabilities to provide preclinical development support for promising products when such products emerge from investigator-initiated research studies. These capabilities will allow NIAID to more rapidly and efficiently close development and production gaps. Activities include but are not limited to small-scale production, preclinical testing and documentation leading to Investigational New Drug (IND) submission for Phase I, II, and III clinical testing. In particular this project will support the immunoaffinity purification of HIV-1 envelope proteins.

## Key facts

- **NIH application ID:** 10610267
- **Project number:** 272201100021I-P00005-27200036-1
- **Recipient organization:** ADVANCED BIOSCIENCE LABORATORIES, INC.
- **Principal Investigator:** THOMAS VANCOTT
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $346,256
- **Award type:** —
- **Project period:** 2016-09-15 → 2021-08-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10610267

## Citation

> US National Institutes of Health, RePORTER application 10610267, NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS (272201100021I-P00005-27200036-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10610267. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*